11 Followers on Owler

Galecto

is a biotechnology firm that develops novel small molecule therapeutics for the treatment of fibrosis and cancer... Read more

Overview Competitors Funding News & Insights

Galecto

is a biotechnology firm that develops novel small molecule therapeutics for the treatment of fibrosis and cancer... Read more

President & CEO

Hans T Schambye

CEO Approval Rating

90/100

2011

CopenhagenCapital Region

PublicIndependent CompanyNASDAQGLTO

Pharmaceuticals & Biotechnology

PharmaceuticalsBiotechnology

28342836 NAICS listing

https://galecto.com/

Annual Revenue

<$1M

Employees

5

News

Conference Presentation

Galecto to Participate in Upcoming Investor Conferences

Galecto Competitors

1

2

3

4

5

6

7

8

9

10

Unlock 11 + competitors

Trending Companies